PortalPublikationenStability and priority of symptoms and symptom clusters amon...

Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study

Standard

Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study. / Esser, Peter; Kuba, Katharina; Scherwath, Angela; Johansen, Christoffer; Schwinn, Anke; Schirmer, Lena; Schulz-Kindermann, Frank; Kruse, Margitta; Koch, Uwe; Zander, Axel Rolf; Kröger, Nicolaus; Götze, Heide; Mehnert, Anja.

in: J PAIN SYMPTOM MANAG, Jahrgang 54, Nr. 4, 2017, S. 493-500.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Esser, P, Kuba, K, Scherwath, A, Johansen, C, Schwinn, A, Schirmer, L, Schulz-Kindermann, F, Kruse, M, Koch, U, Zander, AR, Kröger, N, Götze, H & Mehnert, A 2017, 'Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study', J PAIN SYMPTOM MANAG, Jg. 54, Nr. 4, S. 493-500. https://doi.org/10.1016/j.jpainsymman.2017.07.012

APA

Esser, P., Kuba, K., Scherwath, A., Johansen, C., Schwinn, A., Schirmer, L., Schulz-Kindermann, F., Kruse, M., Koch, U., Zander, A. R., Kröger, N., Götze, H., & Mehnert, A. (2017). Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study. J PAIN SYMPTOM MANAG, 54(4), 493-500. https://doi.org/10.1016/j.jpainsymman.2017.07.012

Vancouver

Esser P, Kuba K, Scherwath A, Johansen C, Schwinn A, Schirmer L et al. Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study. J PAIN SYMPTOM MANAG. 2017;54(4):493-500. https://doi.org/10.1016/j.jpainsymman.2017.07.012

Bibtex

@article{05e4e9be12914c3ca411f06b100fbb29,
title = "Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study",
abstract = "CONTEXT: Due to toxicity and invasiveness, allogeneic HSCT causes severe and longstanding symptom burden. Longitudinal studies on symptoms and symptom clusters (SC) would be helpful to optimize symptom control, but are rare to date.OBJECTIVES: To investigate stability of symptoms, extract time stable SC and to determine their priority in symptom management.METHODS: In this multicenter study, patients diagnosed with hematological cancer were assessed before conditioning (T0) and three months (T1), one year (T2) and five years (T3) after transplantation. Symptoms were assessed with the EORTC-QLQ-C30. Symptoms were stable when rated as present at three consecutive time points. Applying factor analysis, stable SC were composed of symptoms loading on the same factor across all time points. Priority in symptom management was derived from a combination of severity and predictive power for quality of life (QoL).RESULTS: 239 patients participated at T0, 150 (63 %) at T1, 102 (43 %) at T2 and 45 (19 %) at T3. We identified three stable SC, composed of rest-tired-weak-dyspnea-loss of appetite (exhausted), tense-worried-irritable-depressed (affective) and nausea-vomiting (gastrointestinal). Fatigue was most persistent, and also most severe and predictive for QoL, both as symptom and in cluster (exhausted).CONCLUSIONS: Given its high stability, severity and impact on QoL, fatigue should have priority in symptom management. The treatment of this symptom could be enhanced by also incorporating interventions addressing dyspnea and loss of appetite.",
keywords = "Journal Article",
author = "Peter Esser and Katharina Kuba and Angela Scherwath and Christoffer Johansen and Anke Schwinn and Lena Schirmer and Frank Schulz-Kindermann and Margitta Kruse and Uwe Koch and Zander, {Axel Rolf} and Nicolaus Kr{\"o}ger and Heide G{\"o}tze and Anja Mehnert",
note = "Copyright {\textcopyright} 2017. Published by Elsevier Inc.",
year = "2017",
doi = "10.1016/j.jpainsymman.2017.07.012",
language = "English",
volume = "54",
pages = "493--500",
journal = "J PAIN SYMPTOM MANAG",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study

AU - Esser, Peter

AU - Kuba, Katharina

AU - Scherwath, Angela

AU - Johansen, Christoffer

AU - Schwinn, Anke

AU - Schirmer, Lena

AU - Schulz-Kindermann, Frank

AU - Kruse, Margitta

AU - Koch, Uwe

AU - Zander, Axel Rolf

AU - Kröger, Nicolaus

AU - Götze, Heide

AU - Mehnert, Anja

N1 - Copyright © 2017. Published by Elsevier Inc.

PY - 2017

Y1 - 2017

N2 - CONTEXT: Due to toxicity and invasiveness, allogeneic HSCT causes severe and longstanding symptom burden. Longitudinal studies on symptoms and symptom clusters (SC) would be helpful to optimize symptom control, but are rare to date.OBJECTIVES: To investigate stability of symptoms, extract time stable SC and to determine their priority in symptom management.METHODS: In this multicenter study, patients diagnosed with hematological cancer were assessed before conditioning (T0) and three months (T1), one year (T2) and five years (T3) after transplantation. Symptoms were assessed with the EORTC-QLQ-C30. Symptoms were stable when rated as present at three consecutive time points. Applying factor analysis, stable SC were composed of symptoms loading on the same factor across all time points. Priority in symptom management was derived from a combination of severity and predictive power for quality of life (QoL).RESULTS: 239 patients participated at T0, 150 (63 %) at T1, 102 (43 %) at T2 and 45 (19 %) at T3. We identified three stable SC, composed of rest-tired-weak-dyspnea-loss of appetite (exhausted), tense-worried-irritable-depressed (affective) and nausea-vomiting (gastrointestinal). Fatigue was most persistent, and also most severe and predictive for QoL, both as symptom and in cluster (exhausted).CONCLUSIONS: Given its high stability, severity and impact on QoL, fatigue should have priority in symptom management. The treatment of this symptom could be enhanced by also incorporating interventions addressing dyspnea and loss of appetite.

AB - CONTEXT: Due to toxicity and invasiveness, allogeneic HSCT causes severe and longstanding symptom burden. Longitudinal studies on symptoms and symptom clusters (SC) would be helpful to optimize symptom control, but are rare to date.OBJECTIVES: To investigate stability of symptoms, extract time stable SC and to determine their priority in symptom management.METHODS: In this multicenter study, patients diagnosed with hematological cancer were assessed before conditioning (T0) and three months (T1), one year (T2) and five years (T3) after transplantation. Symptoms were assessed with the EORTC-QLQ-C30. Symptoms were stable when rated as present at three consecutive time points. Applying factor analysis, stable SC were composed of symptoms loading on the same factor across all time points. Priority in symptom management was derived from a combination of severity and predictive power for quality of life (QoL).RESULTS: 239 patients participated at T0, 150 (63 %) at T1, 102 (43 %) at T2 and 45 (19 %) at T3. We identified three stable SC, composed of rest-tired-weak-dyspnea-loss of appetite (exhausted), tense-worried-irritable-depressed (affective) and nausea-vomiting (gastrointestinal). Fatigue was most persistent, and also most severe and predictive for QoL, both as symptom and in cluster (exhausted).CONCLUSIONS: Given its high stability, severity and impact on QoL, fatigue should have priority in symptom management. The treatment of this symptom could be enhanced by also incorporating interventions addressing dyspnea and loss of appetite.

KW - Journal Article

U2 - 10.1016/j.jpainsymman.2017.07.012

DO - 10.1016/j.jpainsymman.2017.07.012

M3 - SCORING: Journal article

C2 - 28711754

VL - 54

SP - 493

EP - 500

JO - J PAIN SYMPTOM MANAG

JF - J PAIN SYMPTOM MANAG

SN - 0885-3924

IS - 4

ER -